Remove Governance Remove Medicaid Remove Medicare Remove Patient Advocacy
article thumbnail

CMS Finalizes Major Changes to Hospital Price Transparency Rule

Hall Render

The Centers for Medicare & Medicaid Services (“CMS”) finalized significant updates to the Hospital Price Transparency regulation for the first time since the rule took effect on January 1, 2021.

article thumbnail

For Your Information: Government Response to Long COVID

Total Medical Compliance Resources

FACT SHEET: Biden-Harris Administration Makes Progress in the Whole-of-Government Response to Long COVID U.S. Diagnosis code education: The Centers for Medicare and Medicaid developed educational materials for providers so they can use the new ICD-10 code for Long COVID. Agencies across the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Hospitals Can Help Patients Meet Financial Obligation While Driving Revenue Excellence

HIT Consultant

Today, patients are the third-largest payer – behind Medicaid and Medicare. But the patient’s financial experience is often challenging, even for those with insurance. By focusing on three critical areas, providers can help simplify the process and reduce the staggering patient financial burden.

article thumbnail

White House looks to CMMI to test new ways to lower drug prices

C&M Health Law

The EO comes two months after the president signed the Inflation Reduction Act (IRA) which promises to lower the cost of prescription drugs for many Medicare beneficiaries. This is not the first time that the White House will try to leverage CMMI’s testing authority to create models that would lower drug costs in Medicare.

article thumbnail

TAKE TWO: CMS’s Second Attempt to Streamline Breakthrough Device Coverage Limited to 5 Devices Per Year

Health Law Advisor

On June 22, 2023, the Centers for Medicare & Medicaid Services (CMS) announced its proposed “Transitional Coverage for Technologies” (TCET) pathway—the Biden administration’s highly anticipated take on a mechanism to expedite coverage for certain devices designated by the U.S.

FDA 52